A team led by Stanley Hazen, MD, PhD, receives the first “Program Project” award focused on the gut microbiome. Three related research projects will be supported in a quest for new mechanistic and therapeutic insights.
New research establishes the urinary tract microbiome as a pathogenic target for urinary stone disease, describes the role of bacteria in protective and pathogenic contexts and lays a foundation for future clinical applications.
PPIs are safe and effective drugs — when they are taken as indicated. But there are also risks associated with their use, especially inappropriate use. Drs. Gail Cresci and Amandeep Singh explain.
The physician-scientist draws the American Heart Association’s highest scientific honor for decades of pioneering research in multiple areas.